Single-cell Atlas of common variable immunodeficiency shows germinal center-associated epigenetic dysregulation in B-cell responses

Javier Rodríguez-Ubreva,Anna Arutyunyan,Marc Jan Bonder,Lucía Del Pino-Molina,Stephen J. Clark,Carlos de la Calle-Fabregat,Luz Garcia-Alonso,Louis-François Handfield,Laura Ciudad,Eduardo Andrés-León,Felix Krueger,Francesc Català-Moll,Virginia C. Rodríguez-Cortez,Krzysztof Polanski,Lira Mamanova,Stijn van Dongen,Vladimir Yu. Kiselev,María T. Martínez-Saavedra,Holger Heyn,Javier Martín,Klaus Warnatz,Eduardo López-Granados,Carlos Rodríguez-Gallego,Oliver Stegle,Gavin Kelsey,Roser Vento-Tormo,Esteban Ballestar
DOI: https://doi.org/10.1038/s41467-022-29450-x
IF: 16.6
2022-04-01
Nature Communications
Abstract:Abstract Common variable immunodeficiency (CVID), the most prevalent symptomatic primary immunodeficiency, displays impaired terminal B-cell differentiation and defective antibody responses. Incomplete genetic penetrance and ample phenotypic expressivity in CVID suggest the participation of additional pathogenic mechanisms. Monozygotic (MZ) twins discordant for CVID are uniquely valuable for studying the contribution of epigenetics to the disease. Here, we generate a single-cell epigenomics and transcriptomics census of naïve-to-memory B cell differentiation in a CVID-discordant MZ twin pair. Our analysis identifies DNA methylation, chromatin accessibility and transcriptional defects in memory B-cells mirroring defective cell-cell communication upon activation. These findings are validated in a cohort of CVID patients and healthy donors. Our findings provide a comprehensive multi-omics map of alterations in naïve-to-memory B-cell transition in CVID and indicate links between the epigenome and immune cell cross-talk. Our resource, publicly available at the Human Cell Atlas, gives insight into future diagnosis and treatments of CVID patients.
multidisciplinary sciences
What problem does this paper attempt to address?